Baidu
map
CARDIOVASC DRUG THER 润色咨询

CARDIOVASCULAR DRUGS AND THERAPY

出版年份：1987 年文章数：1040 投稿命中率： 开通期刊会员，数据随心看

出版周期：Bimonthly 自引率：3.7% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2204416, encodeId=1591220441606, content=正在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c735531091, createdName=ms3000000359405274, createdTime=Mon May 13 13:58:25 CST 2024, time=2024-05-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1051775, encodeId=97a91051e75c7, content=今日新投一篇，中稿率20 %，希望杂志快点审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b6f87923, createdName=haitun1987, createdTime=Thu Sep 16 01:59:58 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2156686, encodeId=f9382156686a4, content=哪位知道这个routine article是常规的实验性文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5e065506781, createdName=ms3000000294457894, createdTime=Fri Sep 08 10:59:06 CST 2023, time=2023-09-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=575719, encodeId=79ad5e5719a1, content=投过的大神出来说两句啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32b75167275, createdName=146cc187m12暂无昵称, createdTime=Mon Sep 02 00:00:00 CST 2019, time=2019-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906815, encodeId=abf2906815a8, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：临床药物代谢<br>经验分享：2020年10月20投出 12月10接收 小修 返稿后3个工作日accept 审稿人非常奈斯 建议中肯且友好 给出的建议都是完善文章内容的 会帮你找出参考文献的那种审稿人 语音要求可能比较严格 建议润色后再投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23a75292897, createdName=148691a6m11(暂无昵称), createdTime=Thu Dec 10 19:22:11 CST 2020, time=2020-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801999, encodeId=044f80199903, content=审稿速度:2.0<br>经验分享：投稿后1审一个月，然后两个审稿人和主编都说我语法有问题，但是审稿人没有给很negative的意见，但是感觉对语言还是比较重视，主编就给了拒稿转transfer，但是主编的decision letter 说如果你考虑修改语法并且回答审稿人问题，你可以重新投稿，果断修改后重投。<br>投稿流程本来是 with editor-under review 然后送出去审稿的时候会给通讯作者发邮件说你的稿件已经被选中send out for review了。第二次修改重投给主编写邮件，责任编辑回复说你可以重投，但是我们会像对待全新的稿件来对待，所以我把回复主编的letter 和respond to reviewer 一起附在cover letter 重新投稿了。但是我第二次重新submi之后过了大概10天，分配了编辑然后under review 了，这次并没有给通讯作者发邮件说您的稿件被选中送审。 这说明稿件会送到原来的审稿人吗？<br>现在已经under review 一个月了，希望有好消息……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dbd95390817, createdName=jjjjjjjkkkk, createdTime=Fri Jul 10 07:17:47 CST 2020, time=2020-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887738, encodeId=0e9a88e73896, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：杂志感觉审稿很快，给的意见中肯，身边不少人都投中了，IF一定要稳住！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=321, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bd25420988, createdName=ms9000001184680518, createdTime=Wed Sep 23 19:30:13 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056993, encodeId=1854105699399, content=偏重的研究方向：心血管<br>经验分享：投了一篇 第一次审稿1.5h大修，其中一个审稿人minor rev with accept，另个审稿人也给出比较好的修改建议，修回后2.5周又大修，这次审稿人只有一个小问题，但主编发怒，指出poor English，再次给大修。考虑到springnature旗下期刊于是找他家的润色公司修改论文（ps：之前shinewrite已润色过两轮）。修回，2天后reject。主编说poor write。郁闷中，真不知道说啥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K8uUgwibZgNlyhKUTeUM4DcqLicZoDia9fBNicW8VjdIr7OSA7xhqyvtPHaSafTbrZYyYR0tibAQLrhXV/0, createdBy=c0ff28354, createdName=heyi8686, createdTime=Sat Oct 02 21:05:20 CST 2021, time=2021-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497715, encodeId=08dc49e71534, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：审稿速度还行，我的文章被修改3次接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=474, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Jul 06 16:49:00 CST 2013, time=2013-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799344, encodeId=5e42e9934472, content=反修回去已经两周了，还在editor assigned。不知道怎么样了，担心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEJu51mYJ8xah0twib3tQJXLzZyrGWKRibZTeXvCIibte9RLfeJORzicz4oK2rjcOnicWLIzN5aWuA0yBSw/132, createdBy=135d1941822, createdName=卢克王, createdTime=Mon Jun 22 01:57:41 CST 2020, time=2020-06-22, status=1, ipAttribution=)]
    2024-05-13 ms3000000359405274 来自四川省

    正在投

    3

    展开3条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2204416, encodeId=1591220441606, content=正在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c735531091, createdName=ms3000000359405274, createdTime=Mon May 13 13:58:25 CST 2024, time=2024-05-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1051775, encodeId=97a91051e75c7, content=今日新投一篇，中稿率20 %，希望杂志快点审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b6f87923, createdName=haitun1987, createdTime=Thu Sep 16 01:59:58 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2156686, encodeId=f9382156686a4, content=哪位知道这个routine article是常规的实验性文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5e065506781, createdName=ms3000000294457894, createdTime=Fri Sep 08 10:59:06 CST 2023, time=2023-09-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=575719, encodeId=79ad5e5719a1, content=投过的大神出来说两句啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32b75167275, createdName=146cc187m12暂无昵称, createdTime=Mon Sep 02 00:00:00 CST 2019, time=2019-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906815, encodeId=abf2906815a8, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：临床药物代谢<br>经验分享：2020年10月20投出 12月10接收 小修 返稿后3个工作日accept 审稿人非常奈斯 建议中肯且友好 给出的建议都是完善文章内容的 会帮你找出参考文献的那种审稿人 语音要求可能比较严格 建议润色后再投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23a75292897, createdName=148691a6m11(暂无昵称), createdTime=Thu Dec 10 19:22:11 CST 2020, time=2020-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801999, encodeId=044f80199903, content=审稿速度:2.0<br>经验分享：投稿后1审一个月，然后两个审稿人和主编都说我语法有问题，但是审稿人没有给很negative的意见，但是感觉对语言还是比较重视，主编就给了拒稿转transfer，但是主编的decision letter 说如果你考虑修改语法并且回答审稿人问题，你可以重新投稿，果断修改后重投。<br>投稿流程本来是 with editor-under review 然后送出去审稿的时候会给通讯作者发邮件说你的稿件已经被选中send out for review了。第二次修改重投给主编写邮件，责任编辑回复说你可以重投，但是我们会像对待全新的稿件来对待，所以我把回复主编的letter 和respond to reviewer 一起附在cover letter 重新投稿了。但是我第二次重新submi之后过了大概10天，分配了编辑然后under review 了，这次并没有给通讯作者发邮件说您的稿件被选中送审。 这说明稿件会送到原来的审稿人吗？<br>现在已经under review 一个月了，希望有好消息……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dbd95390817, createdName=jjjjjjjkkkk, createdTime=Fri Jul 10 07:17:47 CST 2020, time=2020-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887738, encodeId=0e9a88e73896, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：杂志感觉审稿很快，给的意见中肯，身边不少人都投中了，IF一定要稳住！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=321, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bd25420988, createdName=ms9000001184680518, createdTime=Wed Sep 23 19:30:13 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056993, encodeId=1854105699399, content=偏重的研究方向：心血管<br>经验分享：投了一篇 第一次审稿1.5h大修，其中一个审稿人minor rev with accept，另个审稿人也给出比较好的修改建议，修回后2.5周又大修，这次审稿人只有一个小问题，但主编发怒，指出poor English，再次给大修。考虑到springnature旗下期刊于是找他家的润色公司修改论文（ps：之前shinewrite已润色过两轮）。修回，2天后reject。主编说poor write。郁闷中，真不知道说啥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K8uUgwibZgNlyhKUTeUM4DcqLicZoDia9fBNicW8VjdIr7OSA7xhqyvtPHaSafTbrZYyYR0tibAQLrhXV/0, createdBy=c0ff28354, createdName=heyi8686, createdTime=Sat Oct 02 21:05:20 CST 2021, time=2021-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497715, encodeId=08dc49e71534, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：审稿速度还行，我的文章被修改3次接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=474, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Jul 06 16:49:00 CST 2013, time=2013-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799344, encodeId=5e42e9934472, content=反修回去已经两周了，还在editor assigned。不知道怎么样了，担心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEJu51mYJ8xah0twib3tQJXLzZyrGWKRibZTeXvCIibte9RLfeJORzicz4oK2rjcOnicWLIzN5aWuA0yBSw/132, createdBy=135d1941822, createdName=卢克王, createdTime=Mon Jun 22 01:57:41 CST 2020, time=2020-06-22, status=1, ipAttribution=)]
    2021-09-16 haitun1987

    今日新投一篇，中稿率20 %，希望杂志快点审

    2

    展开2条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2204416, encodeId=1591220441606, content=正在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c735531091, createdName=ms3000000359405274, createdTime=Mon May 13 13:58:25 CST 2024, time=2024-05-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1051775, encodeId=97a91051e75c7, content=今日新投一篇，中稿率20 %，希望杂志快点审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b6f87923, createdName=haitun1987, createdTime=Thu Sep 16 01:59:58 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2156686, encodeId=f9382156686a4, content=哪位知道这个routine article是常规的实验性文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5e065506781, createdName=ms3000000294457894, createdTime=Fri Sep 08 10:59:06 CST 2023, time=2023-09-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=575719, encodeId=79ad5e5719a1, content=投过的大神出来说两句啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32b75167275, createdName=146cc187m12暂无昵称, createdTime=Mon Sep 02 00:00:00 CST 2019, time=2019-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906815, encodeId=abf2906815a8, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：临床药物代谢<br>经验分享：2020年10月20投出 12月10接收 小修 返稿后3个工作日accept 审稿人非常奈斯 建议中肯且友好 给出的建议都是完善文章内容的 会帮你找出参考文献的那种审稿人 语音要求可能比较严格 建议润色后再投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23a75292897, createdName=148691a6m11(暂无昵称), createdTime=Thu Dec 10 19:22:11 CST 2020, time=2020-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801999, encodeId=044f80199903, content=审稿速度:2.0<br>经验分享：投稿后1审一个月，然后两个审稿人和主编都说我语法有问题，但是审稿人没有给很negative的意见，但是感觉对语言还是比较重视，主编就给了拒稿转transfer，但是主编的decision letter 说如果你考虑修改语法并且回答审稿人问题，你可以重新投稿，果断修改后重投。<br>投稿流程本来是 with editor-under review 然后送出去审稿的时候会给通讯作者发邮件说你的稿件已经被选中send out for review了。第二次修改重投给主编写邮件，责任编辑回复说你可以重投，但是我们会像对待全新的稿件来对待，所以我把回复主编的letter 和respond to reviewer 一起附在cover letter 重新投稿了。但是我第二次重新submi之后过了大概10天，分配了编辑然后under review 了，这次并没有给通讯作者发邮件说您的稿件被选中送审。 这说明稿件会送到原来的审稿人吗？<br>现在已经under review 一个月了，希望有好消息……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dbd95390817, createdName=jjjjjjjkkkk, createdTime=Fri Jul 10 07:17:47 CST 2020, time=2020-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887738, encodeId=0e9a88e73896, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：杂志感觉审稿很快，给的意见中肯，身边不少人都投中了，IF一定要稳住！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=321, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bd25420988, createdName=ms9000001184680518, createdTime=Wed Sep 23 19:30:13 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056993, encodeId=1854105699399, content=偏重的研究方向：心血管<br>经验分享：投了一篇 第一次审稿1.5h大修，其中一个审稿人minor rev with accept，另个审稿人也给出比较好的修改建议，修回后2.5周又大修，这次审稿人只有一个小问题，但主编发怒，指出poor English，再次给大修。考虑到springnature旗下期刊于是找他家的润色公司修改论文（ps：之前shinewrite已润色过两轮）。修回，2天后reject。主编说poor write。郁闷中，真不知道说啥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K8uUgwibZgNlyhKUTeUM4DcqLicZoDia9fBNicW8VjdIr7OSA7xhqyvtPHaSafTbrZYyYR0tibAQLrhXV/0, createdBy=c0ff28354, createdName=heyi8686, createdTime=Sat Oct 02 21:05:20 CST 2021, time=2021-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497715, encodeId=08dc49e71534, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：审稿速度还行，我的文章被修改3次接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=474, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Jul 06 16:49:00 CST 2013, time=2013-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799344, encodeId=5e42e9934472, content=反修回去已经两周了，还在editor assigned。不知道怎么样了，担心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEJu51mYJ8xah0twib3tQJXLzZyrGWKRibZTeXvCIibte9RLfeJORzicz4oK2rjcOnicWLIzN5aWuA0yBSw/132, createdBy=135d1941822, createdName=卢克王, createdTime=Mon Jun 22 01:57:41 CST 2020, time=2020-06-22, status=1, ipAttribution=)]
    2023-09-08 ms3000000294457894 来自北京

    哪位知道这个routine article是常规的实验性文章吗

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2204416, encodeId=1591220441606, content=正在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c735531091, createdName=ms3000000359405274, createdTime=Mon May 13 13:58:25 CST 2024, time=2024-05-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1051775, encodeId=97a91051e75c7, content=今日新投一篇，中稿率20 %，希望杂志快点审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b6f87923, createdName=haitun1987, createdTime=Thu Sep 16 01:59:58 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2156686, encodeId=f9382156686a4, content=哪位知道这个routine article是常规的实验性文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5e065506781, createdName=ms3000000294457894, createdTime=Fri Sep 08 10:59:06 CST 2023, time=2023-09-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=575719, encodeId=79ad5e5719a1, content=投过的大神出来说两句啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32b75167275, createdName=146cc187m12暂无昵称, createdTime=Mon Sep 02 00:00:00 CST 2019, time=2019-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906815, encodeId=abf2906815a8, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：临床药物代谢<br>经验分享：2020年10月20投出 12月10接收 小修 返稿后3个工作日accept 审稿人非常奈斯 建议中肯且友好 给出的建议都是完善文章内容的 会帮你找出参考文献的那种审稿人 语音要求可能比较严格 建议润色后再投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23a75292897, createdName=148691a6m11(暂无昵称), createdTime=Thu Dec 10 19:22:11 CST 2020, time=2020-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801999, encodeId=044f80199903, content=审稿速度:2.0<br>经验分享：投稿后1审一个月，然后两个审稿人和主编都说我语法有问题，但是审稿人没有给很negative的意见，但是感觉对语言还是比较重视，主编就给了拒稿转transfer，但是主编的decision letter 说如果你考虑修改语法并且回答审稿人问题，你可以重新投稿，果断修改后重投。<br>投稿流程本来是 with editor-under review 然后送出去审稿的时候会给通讯作者发邮件说你的稿件已经被选中send out for review了。第二次修改重投给主编写邮件，责任编辑回复说你可以重投，但是我们会像对待全新的稿件来对待，所以我把回复主编的letter 和respond to reviewer 一起附在cover letter 重新投稿了。但是我第二次重新submi之后过了大概10天，分配了编辑然后under review 了，这次并没有给通讯作者发邮件说您的稿件被选中送审。 这说明稿件会送到原来的审稿人吗？<br>现在已经under review 一个月了，希望有好消息……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dbd95390817, createdName=jjjjjjjkkkk, createdTime=Fri Jul 10 07:17:47 CST 2020, time=2020-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887738, encodeId=0e9a88e73896, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：杂志感觉审稿很快，给的意见中肯，身边不少人都投中了，IF一定要稳住！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=321, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bd25420988, createdName=ms9000001184680518, createdTime=Wed Sep 23 19:30:13 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056993, encodeId=1854105699399, content=偏重的研究方向：心血管<br>经验分享：投了一篇 第一次审稿1.5h大修，其中一个审稿人minor rev with accept，另个审稿人也给出比较好的修改建议，修回后2.5周又大修，这次审稿人只有一个小问题，但主编发怒，指出poor English，再次给大修。考虑到springnature旗下期刊于是找他家的润色公司修改论文（ps：之前shinewrite已润色过两轮）。修回，2天后reject。主编说poor write。郁闷中，真不知道说啥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K8uUgwibZgNlyhKUTeUM4DcqLicZoDia9fBNicW8VjdIr7OSA7xhqyvtPHaSafTbrZYyYR0tibAQLrhXV/0, createdBy=c0ff28354, createdName=heyi8686, createdTime=Sat Oct 02 21:05:20 CST 2021, time=2021-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497715, encodeId=08dc49e71534, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：审稿速度还行，我的文章被修改3次接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=474, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Jul 06 16:49:00 CST 2013, time=2013-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799344, encodeId=5e42e9934472, content=反修回去已经两周了，还在editor assigned。不知道怎么样了，担心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEJu51mYJ8xah0twib3tQJXLzZyrGWKRibZTeXvCIibte9RLfeJORzicz4oK2rjcOnicWLIzN5aWuA0yBSw/132, createdBy=135d1941822, createdName=卢克王, createdTime=Mon Jun 22 01:57:41 CST 2020, time=2020-06-22, status=1, ipAttribution=)]
    2019-09-02 146cc187m12暂无昵称

    投过的大神出来说两句啊

    2

    展开2条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2204416, encodeId=1591220441606, content=正在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c735531091, createdName=ms3000000359405274, createdTime=Mon May 13 13:58:25 CST 2024, time=2024-05-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1051775, encodeId=97a91051e75c7, content=今日新投一篇，中稿率20 %，希望杂志快点审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b6f87923, createdName=haitun1987, createdTime=Thu Sep 16 01:59:58 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2156686, encodeId=f9382156686a4, content=哪位知道这个routine article是常规的实验性文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5e065506781, createdName=ms3000000294457894, createdTime=Fri Sep 08 10:59:06 CST 2023, time=2023-09-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=575719, encodeId=79ad5e5719a1, content=投过的大神出来说两句啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32b75167275, createdName=146cc187m12暂无昵称, createdTime=Mon Sep 02 00:00:00 CST 2019, time=2019-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906815, encodeId=abf2906815a8, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：临床药物代谢<br>经验分享：2020年10月20投出 12月10接收 小修 返稿后3个工作日accept 审稿人非常奈斯 建议中肯且友好 给出的建议都是完善文章内容的 会帮你找出参考文献的那种审稿人 语音要求可能比较严格 建议润色后再投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23a75292897, createdName=148691a6m11(暂无昵称), createdTime=Thu Dec 10 19:22:11 CST 2020, time=2020-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801999, encodeId=044f80199903, content=审稿速度:2.0<br>经验分享：投稿后1审一个月，然后两个审稿人和主编都说我语法有问题，但是审稿人没有给很negative的意见，但是感觉对语言还是比较重视，主编就给了拒稿转transfer，但是主编的decision letter 说如果你考虑修改语法并且回答审稿人问题，你可以重新投稿，果断修改后重投。<br>投稿流程本来是 with editor-under review 然后送出去审稿的时候会给通讯作者发邮件说你的稿件已经被选中send out for review了。第二次修改重投给主编写邮件，责任编辑回复说你可以重投，但是我们会像对待全新的稿件来对待，所以我把回复主编的letter 和respond to reviewer 一起附在cover letter 重新投稿了。但是我第二次重新submi之后过了大概10天，分配了编辑然后under review 了，这次并没有给通讯作者发邮件说您的稿件被选中送审。 这说明稿件会送到原来的审稿人吗？<br>现在已经under review 一个月了，希望有好消息……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dbd95390817, createdName=jjjjjjjkkkk, createdTime=Fri Jul 10 07:17:47 CST 2020, time=2020-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887738, encodeId=0e9a88e73896, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：杂志感觉审稿很快，给的意见中肯，身边不少人都投中了，IF一定要稳住！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=321, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bd25420988, createdName=ms9000001184680518, createdTime=Wed Sep 23 19:30:13 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056993, encodeId=1854105699399, content=偏重的研究方向：心血管<br>经验分享：投了一篇 第一次审稿1.5h大修，其中一个审稿人minor rev with accept，另个审稿人也给出比较好的修改建议，修回后2.5周又大修，这次审稿人只有一个小问题，但主编发怒，指出poor English，再次给大修。考虑到springnature旗下期刊于是找他家的润色公司修改论文（ps：之前shinewrite已润色过两轮）。修回，2天后reject。主编说poor write。郁闷中，真不知道说啥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K8uUgwibZgNlyhKUTeUM4DcqLicZoDia9fBNicW8VjdIr7OSA7xhqyvtPHaSafTbrZYyYR0tibAQLrhXV/0, createdBy=c0ff28354, createdName=heyi8686, createdTime=Sat Oct 02 21:05:20 CST 2021, time=2021-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497715, encodeId=08dc49e71534, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：审稿速度还行，我的文章被修改3次接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=474, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Jul 06 16:49:00 CST 2013, time=2013-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799344, encodeId=5e42e9934472, content=反修回去已经两周了，还在editor assigned。不知道怎么样了，担心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEJu51mYJ8xah0twib3tQJXLzZyrGWKRibZTeXvCIibte9RLfeJORzicz4oK2rjcOnicWLIzN5aWuA0yBSw/132, createdBy=135d1941822, createdName=卢克王, createdTime=Mon Jun 22 01:57:41 CST 2020, time=2020-06-22, status=1, ipAttribution=)]
    2020-12-10 148691a6m11(暂无昵称)

    审稿速度:1.0 | 投稿命中率:75.0
    偏重的研究方向：临床药物代谢
    经验分享：2020年10月20投出 12月10接收 小修 返稿后3个工作日accept 审稿人非常奈斯 建议中肯且友好 给出的建议都是完善文章内容的 会帮你找出参考文献的那种审稿人 语音要求可能比较严格 建议润色后再投

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2204416, encodeId=1591220441606, content=正在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c735531091, createdName=ms3000000359405274, createdTime=Mon May 13 13:58:25 CST 2024, time=2024-05-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1051775, encodeId=97a91051e75c7, content=今日新投一篇，中稿率20 %，希望杂志快点审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b6f87923, createdName=haitun1987, createdTime=Thu Sep 16 01:59:58 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2156686, encodeId=f9382156686a4, content=哪位知道这个routine article是常规的实验性文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5e065506781, createdName=ms3000000294457894, createdTime=Fri Sep 08 10:59:06 CST 2023, time=2023-09-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=575719, encodeId=79ad5e5719a1, content=投过的大神出来说两句啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32b75167275, createdName=146cc187m12暂无昵称, createdTime=Mon Sep 02 00:00:00 CST 2019, time=2019-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906815, encodeId=abf2906815a8, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：临床药物代谢<br>经验分享：2020年10月20投出 12月10接收 小修 返稿后3个工作日accept 审稿人非常奈斯 建议中肯且友好 给出的建议都是完善文章内容的 会帮你找出参考文献的那种审稿人 语音要求可能比较严格 建议润色后再投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23a75292897, createdName=148691a6m11(暂无昵称), createdTime=Thu Dec 10 19:22:11 CST 2020, time=2020-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801999, encodeId=044f80199903, content=审稿速度:2.0<br>经验分享：投稿后1审一个月，然后两个审稿人和主编都说我语法有问题，但是审稿人没有给很negative的意见，但是感觉对语言还是比较重视，主编就给了拒稿转transfer，但是主编的decision letter 说如果你考虑修改语法并且回答审稿人问题，你可以重新投稿，果断修改后重投。<br>投稿流程本来是 with editor-under review 然后送出去审稿的时候会给通讯作者发邮件说你的稿件已经被选中send out for review了。第二次修改重投给主编写邮件，责任编辑回复说你可以重投，但是我们会像对待全新的稿件来对待，所以我把回复主编的letter 和respond to reviewer 一起附在cover letter 重新投稿了。但是我第二次重新submi之后过了大概10天，分配了编辑然后under review 了，这次并没有给通讯作者发邮件说您的稿件被选中送审。 这说明稿件会送到原来的审稿人吗？<br>现在已经under review 一个月了，希望有好消息……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dbd95390817, createdName=jjjjjjjkkkk, createdTime=Fri Jul 10 07:17:47 CST 2020, time=2020-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887738, encodeId=0e9a88e73896, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：杂志感觉审稿很快，给的意见中肯，身边不少人都投中了，IF一定要稳住！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=321, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bd25420988, createdName=ms9000001184680518, createdTime=Wed Sep 23 19:30:13 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056993, encodeId=1854105699399, content=偏重的研究方向：心血管<br>经验分享：投了一篇 第一次审稿1.5h大修，其中一个审稿人minor rev with accept，另个审稿人也给出比较好的修改建议，修回后2.5周又大修，这次审稿人只有一个小问题，但主编发怒，指出poor English，再次给大修。考虑到springnature旗下期刊于是找他家的润色公司修改论文（ps：之前shinewrite已润色过两轮）。修回，2天后reject。主编说poor write。郁闷中，真不知道说啥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K8uUgwibZgNlyhKUTeUM4DcqLicZoDia9fBNicW8VjdIr7OSA7xhqyvtPHaSafTbrZYyYR0tibAQLrhXV/0, createdBy=c0ff28354, createdName=heyi8686, createdTime=Sat Oct 02 21:05:20 CST 2021, time=2021-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497715, encodeId=08dc49e71534, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：审稿速度还行，我的文章被修改3次接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=474, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Jul 06 16:49:00 CST 2013, time=2013-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799344, encodeId=5e42e9934472, content=反修回去已经两周了，还在editor assigned。不知道怎么样了，担心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEJu51mYJ8xah0twib3tQJXLzZyrGWKRibZTeXvCIibte9RLfeJORzicz4oK2rjcOnicWLIzN5aWuA0yBSw/132, createdBy=135d1941822, createdName=卢克王, createdTime=Mon Jun 22 01:57:41 CST 2020, time=2020-06-22, status=1, ipAttribution=)]
    2020-07-10 jjjjjjjkkkk

    审稿速度:2.0
    经验分享：投稿后1审一个月，然后两个审稿人和主编都说我语法有问题，但是审稿人没有给很negative的意见，但是感觉对语言还是比较重视，主编就给了拒稿转transfer，但是主编的decision letter 说如果你考虑修改语法并且回答审稿人问题，你可以重新投稿，果断修改后重投。
    投稿流程本来是 with editor-under review 然后送出去审稿的时候会给通讯作者发邮件说你的稿件已经被选中send out for review了。第二次修改重投给主编写邮件，责任编辑回复说你可以重投，但是我们会像对待全新的稿件来对待，所以我把回复主编的letter 和respond to reviewer 一起附在cover letter 重新投稿了。但是我第二次重新submi之后过了大概10天，分配了编辑然后under review 了，这次并没有给通讯作者发邮件说您的稿件被选中送审。 这说明稿件会送到原来的审稿人吗？
    现在已经under review 一个月了，希望有好消息……

    4

    展开4条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2204416, encodeId=1591220441606, content=正在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c735531091, createdName=ms3000000359405274, createdTime=Mon May 13 13:58:25 CST 2024, time=2024-05-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1051775, encodeId=97a91051e75c7, content=今日新投一篇，中稿率20 %，希望杂志快点审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b6f87923, createdName=haitun1987, createdTime=Thu Sep 16 01:59:58 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2156686, encodeId=f9382156686a4, content=哪位知道这个routine article是常规的实验性文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5e065506781, createdName=ms3000000294457894, createdTime=Fri Sep 08 10:59:06 CST 2023, time=2023-09-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=575719, encodeId=79ad5e5719a1, content=投过的大神出来说两句啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32b75167275, createdName=146cc187m12暂无昵称, createdTime=Mon Sep 02 00:00:00 CST 2019, time=2019-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906815, encodeId=abf2906815a8, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：临床药物代谢<br>经验分享：2020年10月20投出 12月10接收 小修 返稿后3个工作日accept 审稿人非常奈斯 建议中肯且友好 给出的建议都是完善文章内容的 会帮你找出参考文献的那种审稿人 语音要求可能比较严格 建议润色后再投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23a75292897, createdName=148691a6m11(暂无昵称), createdTime=Thu Dec 10 19:22:11 CST 2020, time=2020-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801999, encodeId=044f80199903, content=审稿速度:2.0<br>经验分享：投稿后1审一个月，然后两个审稿人和主编都说我语法有问题，但是审稿人没有给很negative的意见，但是感觉对语言还是比较重视，主编就给了拒稿转transfer，但是主编的decision letter 说如果你考虑修改语法并且回答审稿人问题，你可以重新投稿，果断修改后重投。<br>投稿流程本来是 with editor-under review 然后送出去审稿的时候会给通讯作者发邮件说你的稿件已经被选中send out for review了。第二次修改重投给主编写邮件，责任编辑回复说你可以重投，但是我们会像对待全新的稿件来对待，所以我把回复主编的letter 和respond to reviewer 一起附在cover letter 重新投稿了。但是我第二次重新submi之后过了大概10天，分配了编辑然后under review 了，这次并没有给通讯作者发邮件说您的稿件被选中送审。 这说明稿件会送到原来的审稿人吗？<br>现在已经under review 一个月了，希望有好消息……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dbd95390817, createdName=jjjjjjjkkkk, createdTime=Fri Jul 10 07:17:47 CST 2020, time=2020-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887738, encodeId=0e9a88e73896, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：杂志感觉审稿很快，给的意见中肯，身边不少人都投中了，IF一定要稳住！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=321, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bd25420988, createdName=ms9000001184680518, createdTime=Wed Sep 23 19:30:13 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056993, encodeId=1854105699399, content=偏重的研究方向：心血管<br>经验分享：投了一篇 第一次审稿1.5h大修，其中一个审稿人minor rev with accept，另个审稿人也给出比较好的修改建议，修回后2.5周又大修，这次审稿人只有一个小问题，但主编发怒，指出poor English，再次给大修。考虑到springnature旗下期刊于是找他家的润色公司修改论文（ps：之前shinewrite已润色过两轮）。修回，2天后reject。主编说poor write。郁闷中，真不知道说啥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K8uUgwibZgNlyhKUTeUM4DcqLicZoDia9fBNicW8VjdIr7OSA7xhqyvtPHaSafTbrZYyYR0tibAQLrhXV/0, createdBy=c0ff28354, createdName=heyi8686, createdTime=Sat Oct 02 21:05:20 CST 2021, time=2021-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497715, encodeId=08dc49e71534, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：审稿速度还行，我的文章被修改3次接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=474, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Jul 06 16:49:00 CST 2013, time=2013-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799344, encodeId=5e42e9934472, content=反修回去已经两周了，还在editor assigned。不知道怎么样了，担心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEJu51mYJ8xah0twib3tQJXLzZyrGWKRibZTeXvCIibte9RLfeJORzicz4oK2rjcOnicWLIzN5aWuA0yBSw/132, createdBy=135d1941822, createdName=卢克王, createdTime=Mon Jun 22 01:57:41 CST 2020, time=2020-06-22, status=1, ipAttribution=)]
    2020-09-23 ms9000001184680518

    审稿速度:3.0 | 投稿命中率:50.0
    经验分享：杂志感觉审稿很快，给的意见中肯，身边不少人都投中了，IF一定要稳住！

    4

    展开4条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2204416, encodeId=1591220441606, content=正在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c735531091, createdName=ms3000000359405274, createdTime=Mon May 13 13:58:25 CST 2024, time=2024-05-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1051775, encodeId=97a91051e75c7, content=今日新投一篇，中稿率20 %，希望杂志快点审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b6f87923, createdName=haitun1987, createdTime=Thu Sep 16 01:59:58 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2156686, encodeId=f9382156686a4, content=哪位知道这个routine article是常规的实验性文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5e065506781, createdName=ms3000000294457894, createdTime=Fri Sep 08 10:59:06 CST 2023, time=2023-09-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=575719, encodeId=79ad5e5719a1, content=投过的大神出来说两句啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32b75167275, createdName=146cc187m12暂无昵称, createdTime=Mon Sep 02 00:00:00 CST 2019, time=2019-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906815, encodeId=abf2906815a8, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：临床药物代谢<br>经验分享：2020年10月20投出 12月10接收 小修 返稿后3个工作日accept 审稿人非常奈斯 建议中肯且友好 给出的建议都是完善文章内容的 会帮你找出参考文献的那种审稿人 语音要求可能比较严格 建议润色后再投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23a75292897, createdName=148691a6m11(暂无昵称), createdTime=Thu Dec 10 19:22:11 CST 2020, time=2020-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801999, encodeId=044f80199903, content=审稿速度:2.0<br>经验分享：投稿后1审一个月，然后两个审稿人和主编都说我语法有问题，但是审稿人没有给很negative的意见，但是感觉对语言还是比较重视，主编就给了拒稿转transfer，但是主编的decision letter 说如果你考虑修改语法并且回答审稿人问题，你可以重新投稿，果断修改后重投。<br>投稿流程本来是 with editor-under review 然后送出去审稿的时候会给通讯作者发邮件说你的稿件已经被选中send out for review了。第二次修改重投给主编写邮件，责任编辑回复说你可以重投，但是我们会像对待全新的稿件来对待，所以我把回复主编的letter 和respond to reviewer 一起附在cover letter 重新投稿了。但是我第二次重新submi之后过了大概10天，分配了编辑然后under review 了，这次并没有给通讯作者发邮件说您的稿件被选中送审。 这说明稿件会送到原来的审稿人吗？<br>现在已经under review 一个月了，希望有好消息……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dbd95390817, createdName=jjjjjjjkkkk, createdTime=Fri Jul 10 07:17:47 CST 2020, time=2020-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887738, encodeId=0e9a88e73896, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：杂志感觉审稿很快，给的意见中肯，身边不少人都投中了，IF一定要稳住！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=321, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bd25420988, createdName=ms9000001184680518, createdTime=Wed Sep 23 19:30:13 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056993, encodeId=1854105699399, content=偏重的研究方向：心血管<br>经验分享：投了一篇 第一次审稿1.5h大修，其中一个审稿人minor rev with accept，另个审稿人也给出比较好的修改建议，修回后2.5周又大修，这次审稿人只有一个小问题，但主编发怒，指出poor English，再次给大修。考虑到springnature旗下期刊于是找他家的润色公司修改论文（ps：之前shinewrite已润色过两轮）。修回，2天后reject。主编说poor write。郁闷中，真不知道说啥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K8uUgwibZgNlyhKUTeUM4DcqLicZoDia9fBNicW8VjdIr7OSA7xhqyvtPHaSafTbrZYyYR0tibAQLrhXV/0, createdBy=c0ff28354, createdName=heyi8686, createdTime=Sat Oct 02 21:05:20 CST 2021, time=2021-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497715, encodeId=08dc49e71534, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：审稿速度还行，我的文章被修改3次接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=474, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Jul 06 16:49:00 CST 2013, time=2013-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799344, encodeId=5e42e9934472, content=反修回去已经两周了，还在editor assigned。不知道怎么样了，担心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEJu51mYJ8xah0twib3tQJXLzZyrGWKRibZTeXvCIibte9RLfeJORzicz4oK2rjcOnicWLIzN5aWuA0yBSw/132, createdBy=135d1941822, createdName=卢克王, createdTime=Mon Jun 22 01:57:41 CST 2020, time=2020-06-22, status=1, ipAttribution=)]
    2021-10-02 heyi8686

    偏重的研究方向：心血管
    经验分享：投了一篇 第一次审稿1.5h大修，其中一个审稿人minor rev with accept，另个审稿人也给出比较好的修改建议，修回后2.5周又大修，这次审稿人只有一个小问题，但主编发怒，指出poor English，再次给大修。考虑到springnature旗下期刊于是找他家的润色公司修改论文（ps：之前shinewrite已润色过两轮）。修回，2天后reject。主编说poor write。郁闷中，真不知道说啥

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2204416, encodeId=1591220441606, content=正在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c735531091, createdName=ms3000000359405274, createdTime=Mon May 13 13:58:25 CST 2024, time=2024-05-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1051775, encodeId=97a91051e75c7, content=今日新投一篇，中稿率20 %，希望杂志快点审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b6f87923, createdName=haitun1987, createdTime=Thu Sep 16 01:59:58 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2156686, encodeId=f9382156686a4, content=哪位知道这个routine article是常规的实验性文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5e065506781, createdName=ms3000000294457894, createdTime=Fri Sep 08 10:59:06 CST 2023, time=2023-09-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=575719, encodeId=79ad5e5719a1, content=投过的大神出来说两句啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32b75167275, createdName=146cc187m12暂无昵称, createdTime=Mon Sep 02 00:00:00 CST 2019, time=2019-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906815, encodeId=abf2906815a8, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：临床药物代谢<br>经验分享：2020年10月20投出 12月10接收 小修 返稿后3个工作日accept 审稿人非常奈斯 建议中肯且友好 给出的建议都是完善文章内容的 会帮你找出参考文献的那种审稿人 语音要求可能比较严格 建议润色后再投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23a75292897, createdName=148691a6m11(暂无昵称), createdTime=Thu Dec 10 19:22:11 CST 2020, time=2020-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801999, encodeId=044f80199903, content=审稿速度:2.0<br>经验分享：投稿后1审一个月，然后两个审稿人和主编都说我语法有问题，但是审稿人没有给很negative的意见，但是感觉对语言还是比较重视，主编就给了拒稿转transfer，但是主编的decision letter 说如果你考虑修改语法并且回答审稿人问题，你可以重新投稿，果断修改后重投。<br>投稿流程本来是 with editor-under review 然后送出去审稿的时候会给通讯作者发邮件说你的稿件已经被选中send out for review了。第二次修改重投给主编写邮件，责任编辑回复说你可以重投，但是我们会像对待全新的稿件来对待，所以我把回复主编的letter 和respond to reviewer 一起附在cover letter 重新投稿了。但是我第二次重新submi之后过了大概10天，分配了编辑然后under review 了，这次并没有给通讯作者发邮件说您的稿件被选中送审。 这说明稿件会送到原来的审稿人吗？<br>现在已经under review 一个月了，希望有好消息……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dbd95390817, createdName=jjjjjjjkkkk, createdTime=Fri Jul 10 07:17:47 CST 2020, time=2020-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887738, encodeId=0e9a88e73896, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：杂志感觉审稿很快，给的意见中肯，身边不少人都投中了，IF一定要稳住！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=321, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bd25420988, createdName=ms9000001184680518, createdTime=Wed Sep 23 19:30:13 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056993, encodeId=1854105699399, content=偏重的研究方向：心血管<br>经验分享：投了一篇 第一次审稿1.5h大修，其中一个审稿人minor rev with accept，另个审稿人也给出比较好的修改建议，修回后2.5周又大修，这次审稿人只有一个小问题，但主编发怒，指出poor English，再次给大修。考虑到springnature旗下期刊于是找他家的润色公司修改论文（ps：之前shinewrite已润色过两轮）。修回，2天后reject。主编说poor write。郁闷中，真不知道说啥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K8uUgwibZgNlyhKUTeUM4DcqLicZoDia9fBNicW8VjdIr7OSA7xhqyvtPHaSafTbrZYyYR0tibAQLrhXV/0, createdBy=c0ff28354, createdName=heyi8686, createdTime=Sat Oct 02 21:05:20 CST 2021, time=2021-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497715, encodeId=08dc49e71534, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：审稿速度还行，我的文章被修改3次接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=474, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Jul 06 16:49:00 CST 2013, time=2013-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799344, encodeId=5e42e9934472, content=反修回去已经两周了，还在editor assigned。不知道怎么样了，担心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEJu51mYJ8xah0twib3tQJXLzZyrGWKRibZTeXvCIibte9RLfeJORzicz4oK2rjcOnicWLIzN5aWuA0yBSw/132, createdBy=135d1941822, createdName=卢克王, createdTime=Mon Jun 22 01:57:41 CST 2020, time=2020-06-22, status=1, ipAttribution=)]
    2013-07-06 匿名用户

    审稿速度:2.0 | 投稿命中率:50.0
    经验分享：审稿速度还行，我的文章被修改3次接受

    2

    展开2条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2204416, encodeId=1591220441606, content=正在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c735531091, createdName=ms3000000359405274, createdTime=Mon May 13 13:58:25 CST 2024, time=2024-05-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1051775, encodeId=97a91051e75c7, content=今日新投一篇，中稿率20 %，希望杂志快点审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3b6f87923, createdName=haitun1987, createdTime=Thu Sep 16 01:59:58 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2156686, encodeId=f9382156686a4, content=哪位知道这个routine article是常规的实验性文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5e065506781, createdName=ms3000000294457894, createdTime=Fri Sep 08 10:59:06 CST 2023, time=2023-09-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=575719, encodeId=79ad5e5719a1, content=投过的大神出来说两句啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32b75167275, createdName=146cc187m12暂无昵称, createdTime=Mon Sep 02 00:00:00 CST 2019, time=2019-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906815, encodeId=abf2906815a8, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：临床药物代谢<br>经验分享：2020年10月20投出 12月10接收 小修 返稿后3个工作日accept 审稿人非常奈斯 建议中肯且友好 给出的建议都是完善文章内容的 会帮你找出参考文献的那种审稿人 语音要求可能比较严格 建议润色后再投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23a75292897, createdName=148691a6m11(暂无昵称), createdTime=Thu Dec 10 19:22:11 CST 2020, time=2020-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801999, encodeId=044f80199903, content=审稿速度:2.0<br>经验分享：投稿后1审一个月，然后两个审稿人和主编都说我语法有问题，但是审稿人没有给很negative的意见，但是感觉对语言还是比较重视，主编就给了拒稿转transfer，但是主编的decision letter 说如果你考虑修改语法并且回答审稿人问题，你可以重新投稿，果断修改后重投。<br>投稿流程本来是 with editor-under review 然后送出去审稿的时候会给通讯作者发邮件说你的稿件已经被选中send out for review了。第二次修改重投给主编写邮件，责任编辑回复说你可以重投，但是我们会像对待全新的稿件来对待，所以我把回复主编的letter 和respond to reviewer 一起附在cover letter 重新投稿了。但是我第二次重新submi之后过了大概10天，分配了编辑然后under review 了，这次并没有给通讯作者发邮件说您的稿件被选中送审。 这说明稿件会送到原来的审稿人吗？<br>现在已经under review 一个月了，希望有好消息……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dbd95390817, createdName=jjjjjjjkkkk, createdTime=Fri Jul 10 07:17:47 CST 2020, time=2020-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887738, encodeId=0e9a88e73896, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：杂志感觉审稿很快，给的意见中肯，身边不少人都投中了，IF一定要稳住！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=321, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bd25420988, createdName=ms9000001184680518, createdTime=Wed Sep 23 19:30:13 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056993, encodeId=1854105699399, content=偏重的研究方向：心血管<br>经验分享：投了一篇 第一次审稿1.5h大修，其中一个审稿人minor rev with accept，另个审稿人也给出比较好的修改建议，修回后2.5周又大修，这次审稿人只有一个小问题，但主编发怒，指出poor English，再次给大修。考虑到springnature旗下期刊于是找他家的润色公司修改论文（ps：之前shinewrite已润色过两轮）。修回，2天后reject。主编说poor write。郁闷中，真不知道说啥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K8uUgwibZgNlyhKUTeUM4DcqLicZoDia9fBNicW8VjdIr7OSA7xhqyvtPHaSafTbrZYyYR0tibAQLrhXV/0, createdBy=c0ff28354, createdName=heyi8686, createdTime=Sat Oct 02 21:05:20 CST 2021, time=2021-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497715, encodeId=08dc49e71534, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：审稿速度还行，我的文章被修改3次接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=474, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sat Jul 06 16:49:00 CST 2013, time=2013-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799344, encodeId=5e42e9934472, content=反修回去已经两周了，还在editor assigned。不知道怎么样了，担心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEJu51mYJ8xah0twib3tQJXLzZyrGWKRibZTeXvCIibte9RLfeJORzicz4oK2rjcOnicWLIzN5aWuA0yBSw/132, createdBy=135d1941822, createdName=卢克王, createdTime=Mon Jun 22 01:57:41 CST 2020, time=2020-06-22, status=1, ipAttribution=)]
    2020-06-22 卢克王

    反修回去已经两周了，还在editor assigned。不知道怎么样了，担心

    12

    展开12条回复
共67条页码: 1/7页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map